Neuroglee Connect was developed in partnership with Mayo Clinic's HABIT Program with outcomes demonstrated in clinical studies published in Alzheimer's and Dementia.

The Neuroglee Connect solution is a patented, home-based technology program delivered in concert with a virtual physician-led interdisciplinary cognitive care team that improves patient and care partner outcomes across several domains including cognitive self-efficacy, depression, anxiety, stress, care partner burden and medical care plan compliance.

Neuroglee partners with primary care and neurology organizations to serve as a virtual extension of their practice helping them to accurately diagnose, but more importantly, provide rapid access to a solution for patients with MCI and early dementia to improve outcomes and reduced unncessary costs. We support patients at the 'entry point' of cognitive diease and serve as the long-term partner to the subset of patients who progress into more advanced forms of dementia.

Rimidi’s cardiometabolic platform supports disease management of some of the most prevalent and costly chronic conditions. The platform provides access to the tools required to manage multiple disease states – Diabetes, Cardiovascular Disease/Hypertension, Heart Failure, Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH), and Obesity. The platform consolidates relevant clinical data from the EMR for each disease state with patient-generated health data from connected devices or surveys, and layers clinical decision support that can be mapped against national or practice guidelines. Our cardiometabolic snapshot allows clinicians to quickly assess patient status for each comorbid disease state -- are screenings up to date? Are key metrics well-controlled?

The only evidenced-based, clinically proven solution that improves outcomes for patients with Mild Cognitive Impairment and early demential and their care partners.

In the sales process, we often hear “Doesn’t Epic (or other EHR) do that?” Rimidi is not built to replace the EHR, but to enhance it by bringing in additional data sets, providing more efficient workflows, and improving the user experience. Rimidi can install and configure its platform within 3-6 weeks which is significantly faster and more cost effective than onsite EHR teams can build and support enhancements to meet clinical needs. Rimidi’s modern technology stack enables rapid cycle innovation and iteration post-go live.

Rimidi’s cardiometabolic platform is most often compared to other Remote Patient Monitoring solutions, but the platform-approach to RPM allows Rimidi to do so much more. Some key differentiators of the Rimidi platform are: (1) tight integration with leading EHRs via SMART on FHIR, (2) the breadth of the comorbid disease states we cover, (3) our incorporations of patient-reported outcomes and social determinants of health measures and (4) our Clinical Decision Support engine. Rimidi’s CDS cards support almost any insight or intervention a client wants: RPM data alerting and interventions, referral management, lab or medication recommendations, clinical trial identification, and more.